Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cell Block Technique Detects Low Frequency Abnormal Cells

By LabMedica International staff writers
Posted on 15 Jan 2013
Different cell block techniques have been compared for the detection of low frequency abnormal cells and representative sampling with simple sedimentation.

Automated cell block systems rapidly create paraffin-embedded cell blocks by using vacuum filtration to deposit a layer of cells on a filter and infiltrate those cells with reagents and paraffin.

Scientists at Hologic Inc (Marlborough, MA, USA) compared three cell block systems using a novel tracer-cell model consisting of epidermoid carcinoma (CaSki) cells (American Type Culture Collection; Manassas, VA, USA). More...
The cells were prestained in solution with hematoxylin and serially diluted in a background of pooled clinical serous effusion specimens and quantified using a hemocytometer. Ten replicates diluted cells were processed using each cell block method, and the resulting blocks were cut to produce two slides from each block. The slides were deparaffinized, counterstained with eosin, cover-slipped, and screened for the presence of tracer cells.

Tracer cells were identified on the initial slides for 20 of 40 simple sedimentation cell blocks, 21 of 40 in Richard-Allan HistoGel cell blocks (Thermo Scientific, Waltham, MA, USA), and 25 of 40 Hologic's Cellient cell blocks. All three methods showed representative sampling in 100% of the blocks made from the 100 tracer/mL specimen. With blocks made from the 10 tracer/mL specimen, simple sedimentation, HistoGel, and Cellient showed 90.0%, 80.0%, and 100% representative sampling, respectively. Representative sampling at the 1 tracer/mL dilution was 10.0% for simple sedimentation and 30% for HistoGel and Cellient. At the 0.1 tracer/mL dilution, only Cellient showed representative sampling.

The authors concluded that the detection of low concentration CaSki tracer cells was greater in Cellient cell blocks compared with simple sedimentation and HistoGel cell blocks. The Cellient cell blocks required the least amount of recutting, and demonstrated representative sampling at the lowest tracer cell concentration. A benefit of the Cellient system is that it concentrates cellular material on a membrane filter, resulting in a cell block with all the cells at or near the face of the block. The study was published on January 3, 2013, in the journal Pathology and Laboratory Medicine International.

Related Links:

Hologic Inc.
American Type Culture Collection
Thermo Scientific



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.